Most users describe this period as "something is happening but nothing dramatic." Weeks 2-3: More noticeable improvements in pain, mobility, and function
(It probably also doesnt help that peptides are commonly injected, likely causing many people to associate them with steroids, although GLP-1s have done a lot to move past that taboo.) But a potential recategorization of these peptides could change all of that
Using them continuously, you will act according to the principle that prevention is better than cure
Consequently, it can lead to improved overall health, wellness, and liver function
2,3 In REDEFINE 1, adverse events were mainly gastrointestinal, (79.6% in the CagriSema group vs 39.9% with placebo) including nausea (55% vs 12.6%), constipation (30.7% vs 11.6%), and vomiting (26.1% vs 4.1%)